Death rate for younger women with breast cancer poised to climb
February 9, 2021 -- The death rate for women under 40 with breast cancer in the U.S. used to be waning, but it is now poised to rise, along with an increased incidence in distant-stage breast cancer, according to a new study in Radiology. Read More
Study makes case for baseline mammography exam at age 40
February 8, 2021 -- A baseline mammography exam at age 40 for average-risk women to identify breast density appears to be cost-effective, according to a study published February 8 in the Annals of Internal Medicine. Read More
SmartBreast buys molecular breast imaging business from GE
February 8, 2021 -- Breast cancer screening firm SmartBreast has acquired assets related to the Discovery NM750b molecular breast imaging (MBI) business of GE Healthcare, including scanner designs, patents, and service contracts for GE's MBI installed base. Read More
Breast cancer surpasses lung as most common worldwide
February 4, 2021 -- Breast cancer in women has surpassed lung cancer as the most commonly diagnosed type of cancer worldwide, according to a new report published February 4 in CA: A Cancer Journal for Clinicians. Read More
Outdoor work linked to lower risk of breast cancer
February 4, 2021 -- Working outdoors may come with the benefit of a lower risk of breast cancer, according to a study published on February 1 in Occupational & Environmental Medicine. Researchers found working outdoors for decades was tied to a lower breast cancer risk for women ages 50 or older. Read More
Volpara acquires risk assessment firm CRA Health
February 1, 2021 -- Breast imaging software developer Volpara has acquired CRA Health, a developer of breast cancer risk assessment software that is a spinoff of Massachusetts General Hospital. Read More
Dr. Daniel Kopans: Will the USPSTF heed science on breast screening?
January 29, 2021 -- The U.S. Preventive Services Task Force (USPSTF) has begun a review of its guidelines on breast screening. Dr. Daniel Kopans believes the task force should heed the established science on mammography and recommend screening of women in their 40s. Read More
Special Feature
Should breast ultrasound scans after COVID vaccines be postponed?

When using ultrasound to follow up on suspicious breast masses in patients who just got a second dose of a COVID-19 vaccine, it may be wise to postpone scans to between 12 and 16 weeks to reduce unnecessary biopsies, according to research published in the American Journal of Roentgenology. Read more

Breast Ultrasound Course
January 27-29
Houston, Texas United States
American Society of Spine Radiology 26th Annual Symposium
February 8-12
Charleston, South Carolina United States
University of California, San Francisco Breast Imaging Update
February 26 - March 3
Kamuela, Hawaii United States
Ultrasound - Obstetrics and Gynecology Workshop
March 5
Noosaville, Queensland Australia